West Pharmaceutical Services stock falls 3.33% and underperforms competitors
Updated
Updated · MarketWatch · Apr 28
West Pharmaceutical Services stock falls 3.33% and underperforms competitors
11 articles · Updated · MarketWatch · Apr 28
Shares closed at $292.13 on Tuesday, marking a third straight day of losses and trading 9.37% below the 52-week high.
Trading volume reached 1.2 million, surpassing the 50-day average of 901,184, as the S&P 500 and Dow Jones also declined.
While West Pharmaceutical Services underperformed, competitor Abbott Laboratories rose 1.14%, and Becton Dickinson and Baxter International saw smaller declines amid a broadly negative market session.
With record earnings and a GLP-1 boom, why is West Pharmaceutical's stock tumbling?
Down 9% from its high, is now the time to buy this Dividend Aristocrat?
Is West Pharmaceutical's premium valuation a ticking time bomb for investors?
Can the GLP-1 surge protect West Pharmaceutical from market headwinds and rivals?
How will US onshoring policies affect West Pharmaceutical's manufacturing dominance?